生命科学资讯
生物技术与制药领域的最新动态
Even Europeans don't see a future in Euro biopharma anymore
Terray says its AI model beats Boltz-2 at binding affinity prediction
Lyell starts first head-to-head CAR-T therapy trial
BridgeBio's dwarfism drug succeeds in Phase 3, adding to recent late-stage wins
欧洲风投组建联盟以争取更多生物科技投资支持。
European VCs form coalition to get more support for biotech investing
赛诺菲CEO保罗·哈德森卸任，贝伦·加里霍将接任新首席执行官。
Sanofi's Paul Hudson out, with Belén Garijo to step in as new CEO
Hinge Health计划开发用于心理健康支持的AI工具
Hinge Health is looking to build AI tools for mental health support
FDA或考虑在更小范围使用Moderna流感疫苗
FDA may consider Moderna's flu vaccine in a narrower group
前阿斯利康高管在华被控非法交易
Former AstraZeneca senior staff charged with illegal trade in China
普拉萨德否决疫苗审查团队及办公室主管对Moderna流感疫苗的建议。
Prasad overruled vaccine review team, office director on Moderna flu shot
CEO离职后，CSL披露利润暴跌及11亿美元减值成本
After CEO departs, CSL details profit crash, $1.1B impairment costs
Madrigal公司从中国瑞博生物引进六种siRNA以充实MASH治疗管线。
Madrigal pads MASH pipeline with six siRNAs from China's Ribo
古布拉成立风险投资部门；加莱克托完成2.75亿美元融资。
Gubra forms venture unit; Galecto's $275M offering
一柜子心电图机如何揭示药企临床试验成本问题
How a closet full of EKG machines illustrates pharma’s clinical trial cost problem
奥斯卡健康预计2026年将迎来爆发式增长，但伴随风险。
Oscar Health expects explosive growth for 2026, but it comes with a risk
事后直播：生物技术与FDA的关系是否濒临破裂？
Post-Hoc Live: Is biotech’s relationship with the FDA at a breaking point?
Upstream Bio宣布verekitug在重度哮喘二期试验中取得积极数据。
Upstream Bio says verekitug delivered positive data in Phase 2 severe asthma trial
Moderna指控FDA改变标准，拒绝审查其流感疫苗。
Moderna accuses FDA of shifting standard as agency refuses flu shot review
同构科技宣布其新型AI药物设计引擎取得重大突破。
Isomorphic claims major advance with new AI drug design engine